senicapoc has been researched along with rubidium in 1 studies
| Studies (senicapoc) | Trials (senicapoc) | Recent Studies (post-2010) (senicapoc) | Studies (rubidium) | Trials (rubidium) | Recent Studies (post-2010) (rubidium) |
|---|---|---|---|---|---|
| 42 | 3 | 32 | 5,163 | 18 | 269 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beuzard, Y; Brugnara, C; Corrocher, R; De Franceschi, L; McNaughton-Smith, GA; Stocker, JW | 1 |
1 other study(ies) available for senicapoc and rubidium
| Article | Year |
|---|---|
ICA-17043, a novel Gardos channel blocker, prevents sickled red blood cell dehydration in vitro and in vivo in SAD mice.
Topics: Acetamides; Anemia, Sickle Cell; Animals; Calcium; Calcium Channel Blockers; Clotrimazole; Erythrocytes; Female; Humans; Hypoxia; Male; Mice; Mice, Transgenic; Potassium Channels, Calcium-Activated; Rubidium; Trityl Compounds | 2003 |